← Back to Search

Short Walks for COPD (COPD Trial)

N/A
Recruiting
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30, 60, 90, 120, 150 and 180 minutes of sitting (day1) or within 30, 60, 90, 120, 150 and 180 minutes of sitting broken up by micro-doses of physical activity (day 2). days performed in a randomized order.
Awards & highlights

COPD Trial Summary

This trial will study how sitting still affects COPD patients' blood vessel health and if short walks can help.

Who is the study for?
This trial is for non-smoking individuals with stable moderate-to-severe COPD who haven't smoked in over 6 months. Participants should have a specific level of lung function and not be on anticoagulants, diabetic, or have musculoskeletal issues that limit physical activity. They shouldn't have severe heart or brain blood vessel disease or a history of deep vein thrombosis.Check my eligibility
What is being tested?
The study looks at the effects of sitting still for three hours versus breaking up this time with short walking breaks every hour on blood vessel health in people with COPD. The goal is to see if these micro-doses of activity can help maintain healthy blood vessels.See study design
What are the potential side effects?
Since the intervention involves light physical activity, potential side effects may include mild discomfort or fatigue during exercise. However, as it's low intensity and self-paced, serious side effects are unlikely.

COPD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30, 60, 90, 120, 150 and 180 minutes of sitting (day1) or within 30, 60, 90, 120, 150 and 180 minutes of sitting broken up by micro-doses of physical activity (day 2). days performed in a randomized order.
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30, 60, 90, 120, 150 and 180 minutes of sitting (day1) or within 30, 60, 90, 120, 150 and 180 minutes of sitting broken up by micro-doses of physical activity (day 2). days performed in a randomized order. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in superficial femoral artery endothelial function
Secondary outcome measures
Change in superficial femoral artery blood flow patterns
Difference in 24-hour ambulatory blood pressure between the two conditions
Other outcome measures
Change in central arterial stiffness
Body Weight Changes
Time course of change in endothelial function of the superficial femoral artery
+1 more

COPD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Microdoses of ActivityExperimental Treatment1 Intervention
5-min bouts of walking will break up 3 hours of sitting at minutes 30, 90 and 150.
Group II: ControlActive Control1 Intervention
Prolonged sitting (3 hours)

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,418 Previous Clinical Trials
2,467,098 Total Patients Enrolled

Media Library

Microdoses of activity Clinical Trial Eligibility Overview. Trial Name: NCT05553223 — N/A
Microdoses of activity 2023 Treatment Timeline for Medical Study. Trial Name: NCT05553223 — N/A
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Microdoses of activity Highlights & Side Effects. Trial Name: NCT05553223 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: Control, Microdoses of Activity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any vacancies for participants in this clinical research project?

"Per clinicaltrials.gov, this clinical trial is currently in search of test subjects. The first listing was published on October 12th 2022 and the most recent update occurred on the same date."

Answered by AI

How many individuals are currently participating in this trial?

"Affirmative. According to the information available on clinicaltrials.gov, this trial is currently recruiting participants and was initially advertised on October 12th 2022. The most recent update took place on that same day and the recruitment of 20 individuals across one site is necessary for completion."

Answered by AI

Who else is applying?

What state do they live in?
California
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Micro-doses of Physical Activity for COPD
Neil Eves 2022. "Micro-doses of Physical Activity for COPD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05553223.
~4 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top